FdaApplication

ANDA 213085

Back to search

Identifiers

Properties

PropertyValue
applicant_namePIRAMAL HEALTHCARE UK LTD
application_typeANDA
approval_date2023-07-25

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL

2 products